Tengion, Inc.

Tengion, Inc.

TNGNQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$402
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Tengion, Inc.Tengion, Inc.0-87%--0.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$402.00
Enterprise Value$28.39 Million
Earnings per Share$-6.6
Beta1.94
Outstanding Shares25,171,000

Return

Return on Equity86.65%ROE
Return on Assets-750.95%
Return on Invested Capital113.37%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.5
Enterprise Value to Net Income-1
Total Debt to Enterprise1.2
Debt to Equity-0.41Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Tengion, Inc.

25 employees
CEO: David I. Scheer

Tengion, Inc. was a biotechnology company focused on regenerative medicine, established in 2003 and headquartered in Winston-Salem, North Carolina. Its primary objective was the discovery, development, manufacturing, and commercializatio...

Questions & Answers